JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB134056

Anti-XRCC1 antibody [EPR4389(2)]

5

(3 Reviews)

|

(25 Publications)

Rabbit Recombinant Monoclonal XRCC1 antibody. Suitable for WB, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 25 publications.

View Alternative Names

DNA repair protein XRCC1, X-ray repair cross-complementing protein 1, XRCC1

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

Immunofluorescent analysis of HeLa cells labelling XRCC1 with ab134056 at 1/100 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • ICC/IF

AbReview40413****

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

ab134056 staining XRCC1 in human HeLa cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde and permeabilized with 0.5% Triton X-100 in PBS. Samples were incubated with primary antibody (1/200 in PBS) for 1 hour at 22°C. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG polyclonal (1/200) was used as the secondary antibody. Counterstained with DAPI.

This image is courtesy of an Abreview submitted by Kirk McManus

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

Immunocytochemistry/Immunofluorescence analysis of PC-12(Rat adrenal gland pheochromocytoma) labelling with ab134056 at a dilution of 1/50 dilution (4.66 μg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) (1/1000 dilution (2 μg/mL)) was used as the secondary antibody. The cells were co-stained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Nuclei counterstained with DAPI (blue). Control : PBS instead of the primary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

Immunocytochemistry/Immunofluorescence analysis of NIH/3T3(Mouse embryonic fibroblast) labelling with ab134056 at a dilution of 1/50 (4.66 μg/mL). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) at 1/1000 dilution (2 μg/mL)) was used as the secondary antibody. The cells were co-stained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Nuclei counterstained with DAPI (blue). Control : PBS instead of the primary antibody.

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • WB

Unknown

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

All lanes:

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (ab134056) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

A375 cell lysate at 10 µg

Lane 3:

Saos-2 cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 69 kDa

false

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)
  • WB

Lab

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (AB134056)

Blocking/Diluting buffer : 5% NFDM /TBST

Exposure time :
Lanes 1-2 : 3 minutes
Lanes 3-4 : 20 seconds

All lanes:

Western blot - Anti-XRCC1 antibody [EPR4389(2)] (ab134056) at 1/2000 dilution

Lane 1:

Mouse brain tissue lysate at 20 µg

Lane 2:

Mouse kidney lysate at 20 µg

Lane 3:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg

Lane 4:

NIH/3T3(Mouse embryonic fibroblast) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated(Pierce) at 1/1000 dilution

Predicted band size: 69 kDa

Observed band size: 85 kDa

false

  • Carrier free

    Anti-XRCC1 antibody [EPR4389(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4389(2)

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

XRCC1 (X-ray repair cross-complementing protein 1) plays a role in DNA repair by acting as a scaffold protein. It weighs approximately 70 kDa and is expressed in various tissues reflecting its role in maintaining genomic stability. XRCC1 helps in the repair of single-strand breaks by coordinating the activity of several enzymes involved in the base excision repair pathway. Together with other proteins it helps ensure the integrity of DNA by fostering repair mechanisms following damage by ionizing radiation or other environmental factors.
Biological function summary

The activity of XRCC1 integrates into DNA damage response as it partners with enzymes like DNA ligase III DNA polymerase beta and poly (ADP-ribose) polymerase (PARP). This protein functions by forming complexes with these enzymes facilitating quick and accurate repair. The ability of XRCC1 to bring together repair machinery is essential for cell survival after DNA damage and plays a role in the prevention of mutagenesis and carcinogenesis as errors in repair processes could lead to genetic mutations.

Pathways

The XRCC1 protein participates in base excision repair and single-strand break repair pathways. It works closely with PARP1 and DNA ligase III to correct single-strand DNA interruptions. Through these pathways XRCC1 interacts with other repair proteins like TDP1 aiding in the resolution of complex DNA end structures. This collaboration ensures the completion of cellular repair processes maintaining genomic integrity and reducing the likelihood of accumulating harmful mutations.

Mutations in XRCC1 have links to cancer development particularly those involving increased susceptibility to tobacco-related cancers. Studies have connected XRCC1 polymorphisms to a higher risk for conditions such as breast and lung cancer. Relations between XRCC1 and disorders can also be observed with neurodegenerative conditions; for instance alterations in its function or expression patterns might amplify disease progression involving neurological decline. Moreover its interactions with proteins like PARP1 bring forth potential implications in therapeutic strategies aiming to exploit DNA repair pathways for targeted cancer treatments.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Scaffold protein involved in DNA single-strand break repair by mediating the assembly of DNA break repair protein complexes (PubMed : 11163244, PubMed : 28002403). Negatively regulates ADP-ribosyltransferase activity of PARP1 during base-excision repair in order to prevent excessive PARP1 activity (PubMed : 28002403, PubMed : 34102106, PubMed : 34811483). Recognizes and binds poly-ADP-ribose chains : specifically binds auto-poly-ADP-ribosylated PARP1, limiting its activity (PubMed : 14500814, PubMed : 34102106, PubMed : 34811483).
See full target information XRCC1

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

Cell death and differentiation 31:792-803 PubMed38664591

2024

The cGAS-Ku80 complex regulates the balance between two end joining subpathways.

Applications

Unspecified application

Species

Unspecified reactive species

Haiping Zhang,Lijun Jiang,Xinyi Du,Zhen Qian,Guizhu Wu,Ying Jiang,Zhiyong Mao

Nucleic acids research 52:5107-5120 PubMed38554113

2024

SIRT2 promotes base excision repair by transcriptionally activating OGG1 in an ATM/ATR-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Anke Geng,Jiahui Sun,Huanyin Tang,Yang Yu,Xiyue Wang,Jingyuan Zhang,Xiaona Wang,Xiaoxiang Sun,Xiaofang Zhou,Neng Gao,Rong Tan,Zhu Xu,Ying Jiang,Zhiyong Mao

Nature communications 15:2599 PubMed38521768

2024

FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Cong,Nathan MacGilvary,Silviana Lee,Shannon G MacLeod,Jennifer Calvo,Min Peng,Arne Nedergaard Kousholt,Tovah A Day,Sharon B Cantor

Journal of cancer research and clinical oncology 150:30 PubMed38270643

2024

The mA demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance.

Applications

Unspecified application

Species

Unspecified reactive species

Yichen He,Yimeng Chen,Zhengsheng Li,Changping Wu

Journal of cellular and molecular medicine 28:e18033 PubMed38009603

2023

Ailanthone synergizes with PARP1 inhibitor in tumour growth inhibition through crosstalk of DNA repair pathways in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chunming Wang,Tingzhuang Yi,Xiangde Li,Jiarui Cui,Biqi Li,Yankai Qin,Shixiong Tang,Jianfeng Zhang

Journal of translational medicine 21:679 PubMed37773127

2023

Cytosine-phosphate-guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Deyu Zhang,Shitai Zhang,Zheng He,Ying Chen

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2206896 PubMed36814305

2023

circCIMT Silencing Promotes Cadmium-Induced Malignant Transformation of Lung Epithelial Cells Through the DNA Base Excision Repair Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Meizhen Li,Wei Chen,Jinjin Cui,Qiuyi Lin,Yufei Liu,Huixian Zeng,Qiuhan Hua,Yihui Ling,Xiaodi Qin,Yindai Zhang,Xueqi Li,Tianshu Lin,Lihua Huang,Yiguo Jiang

Cancer discovery 12:2586-2605 PubMed36001024

2022

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Meenakshi Anurag,Eric J Jaehnig,Karsten Krug,Jonathan T Lei,Erik J Bergstrom,Beom-Jun Kim,Tanmayi D Vashist,Anh Minh Tran Huynh,Yongchao Dou,Xuxu Gou,Chen Huang,Zhiao Shi,Bo Wen,Viktoriya Korchina,Richard A Gibbs,Donna M Muzny,Harshavardhan Doddapaneni,Lacey E Dobrolecki,Henry Rodriguez,Ana I Robles,Tara Hiltke,Michael T Lewis,Julie R Nangia,Maryam Nemati Shafaee,Shunqiang Li,Ian S Hagemann,Jeremy Hoog,Bora Lim,C Kent Osborne,D R Mani,Michael A Gillette,Bing Zhang,Gloria V Echeverria,George Miles,Mothaffar F Rimawi,Steven A Carr,Foluso O Ademuyiwa,Shankha Satpathy,Matthew J Ellis

BioMed research international 2022:8568528 PubMed35872860

2022

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair.

Applications

Unspecified application

Species

Unspecified reactive species

Wenhui Jiao,Shan Zhu,Jingrong Shao,Xiaoliang Zhang,Yanglu Xu,Yixuan Zhang,Ran Wang,Yuxu Zhong,Dexin Kong

Nature 606:930-936 PubMed35477155

2022

Breakage of cytoplasmic chromosomes by pathological DNA base excision repair.

Applications

Unspecified application

Species

Unspecified reactive species

Shangming Tang,Ema Stokasimov,Yuxiang Cui,David Pellman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com